3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Head and Neck: new trials by email Literature Review of Head and Neck trials Research Report on Head and Neck
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Identification of Nerves Using Fluorescein Sodium Fluorescein Sodium - Pleomorphic Adenoma of the Parotid, Warthin Tumor | Phase 2 | Completed | Stanford University | 8 | 2024-11-07 | 2026-05-20 |
| Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer cetuximab - Head and Neck, Squamous Cell Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 61 | 2007-11-01 | 2018-01-11 |
| A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer Hydroxyurea, 5- Fluorouracil, Cisplatin - Head and Neck | Phase 2 | Completed | University of Chicago | 44 | 2003-03-01 | 2024-01-29 |
Adenolymphoma (1) · Head and Neck Neoplasms (1) · Laryngeal Diseases (1) · Neoplasms (1) · Neoplasms, Squamous Cell (1) · Thyroid Diseases (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Endocrine System Diseases (1) · Neoplasms by Site (1) · Neoplasms, Complex and Mixed (1) · Neoplasms, Glandular and Epithelial (1) · Otorhinolaryngologic Diseases (1) · Respiratory Tract Diseases (1)
Cetuximab (1) · Cisplatin (1) · Fluorescein (1) · Fluorouracil (1) · Hydroxyurea (1)
Memorial Sloan Kettering Cancer Center (1) · Stanford University (1) · University of Chicago (1)
United States (3)
Everett Vokes, MD (1) · Matthew Fury, MD,PhD (1) · Tulio Valdez, MD (1)
R25DC020174 (1)